Cargando…
In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation
A biowaiver is accepted by the Brazilian Health Surveillance Agency (ANVISA) for immediate-release solid oral products containing Biopharmaceutics Classification System (BCS) class I drugs showing rapid drug dissolution. This study aimed to simulate plasma concentrations of fluconazole capsules with...
Autores principales: | Duque, Marcelo Dutra, Silva, Daniela Amaral, Issa, Michele Georges, Porta, Valentina, Löbenberg, Raimar, Ferraz, Humberto Gomes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571621/ https://www.ncbi.nlm.nih.gov/pubmed/31060289 http://dx.doi.org/10.3390/pharmaceutics11050215 |
Ejemplares similares
-
Development of a Discriminative Dissolution Method, Using In-Silico Tool for Hydrochlorothiazide and Valsartan Tablets
por: Leon, Rosmery Merma, et al.
Publicado: (2023) -
Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023) -
In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing
por: Al-Tabakha, Moawia M., et al.
Publicado: (2020) -
Biphasic Dissolution as an Exploratory Method during Early Drug Product Development
por: Amaral Silva, Daniela, et al.
Publicado: (2020) -
Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models
por: Uebbing, Lukas, et al.
Publicado: (2017)